These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8494371)

  • 21. [Identification and sensitivity of acinetobacter sp isolated from clinical specimens and hospital environment].
    Martínez MA; Pinto ME; Giglio MS; Pommier J; Muñoz LM
    Rev Med Chil; 1992 Nov; 120(11):1267-72. PubMed ID: 1340947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
    Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
    Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
    Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus.
    Chow AW; Wong J; Bartlett KH
    Diagn Microbiol Infect Dis; 1988 Apr; 9(4):213-7. PubMed ID: 3180706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
    Eser OK; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.
    Karlowsky JA; Draghi DC; Jones ME; Thornsberry C; Friedland IR; Sahm DF
    Antimicrob Agents Chemother; 2003 May; 47(5):1681-8. PubMed ID: 12709340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibility pattern of Acinetobacter species to commonly used cephalosporins, quinolones, and aminoglycosides.
    Prashanth K; Badrinath S
    Indian J Med Microbiol; 2004; 22(2):97-103. PubMed ID: 17642704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of multidrug-resistant isolates of Acinetobacter baumannii.
    Okpara AU; Maswoswe JJ
    Am J Hosp Pharm; 1994 Nov; 51(21):2671-5. PubMed ID: 7856578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
    Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
    Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial resistance of different Acinetobacter baumannii biotypes isolated in the northern region of Chile].
    Silva J; Avello C; Matamoro F; Villagra L; Rojas V; Sandoval L
    Rev Med Chil; 1999 Aug; 127(8):926-34. PubMed ID: 10752253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].
    Ciftci IH; Aşık G; Karakeçe E; Oksüz L; Yağcı S; Sesli Çetin E; Ozdemir M; Atasoy AR; Koçoğlu E; Gül M; Kurtoğlu MG; Köksal Çakırlar F; Seyrek A; Berktaş M; Gültepe B; Ayyildiz A
    Mikrobiyol Bul; 2013 Oct; 47(4):592-602. PubMed ID: 24237428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility of Acinetobacter strains identified by DNA-DNA hybridization.
    Tjernberg I
    APMIS; 1990 Apr; 98(4):320-6. PubMed ID: 2354051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
    Park YK; Jung SI; Park KH; Kim DH; Choi JY; Kim SH; Ko KS
    J Med Microbiol; 2012 Jan; 61(Pt 1):71-79. PubMed ID: 21852525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel.
    Simhon A; Rahav G; Shazberg G; Block C; Bercovier H; Shapiro M
    J Clin Microbiol; 2001 Jan; 39(1):389-91. PubMed ID: 11136809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.
    Visalli MA; Jacobs MR; Moore TD; Renzi FA; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Apr; 41(4):767-70. PubMed ID: 9087486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Lee JH; Choi CH; Kang HY; Lee JY; Kim J; Lee YC; Seol SY; Cho DT; Kim KW; Song DY; Lee JC
    J Antimicrob Chemother; 2007 Apr; 59(4):633-9. PubMed ID: 17339277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amikacin-resistant Acinetobacter species mediated by the aphA6 gene associated with clinical outcome at an academic complex hospital in KwaZulu-Natal Province, South Africa.
    Swe Swe-Han K; Pillay M; Pillay M
    S Afr Med J; 2019 Dec; 110(1):49-54. PubMed ID: 31865943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.